Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21001 AL 21015

Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia

Giorgi FS, Biagioni F, Galgani A, Pavese N, Lazzeri G, Fornai F.

Int J Mol Sci. 2020 Nov 16;21(22):8630. doi: 10.3390/ijms21228630.

Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies

Zaghmi A, Drouin-Ouellet J, Brambilla D, Gauthier MA.

Biomaterials. 2021 Feb;269:120461. doi: 10.1016/j.biomaterials.2020.120461. Epub 2020 Nov 6.

Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease

Kim N, Lee HJ.

Biomed Res Int. 2020 Nov 9;2020:2010728. doi: 10.1155/2020/2010728. eCollection 2020.

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

Jensen NJ, Wodschow HZ, Nilsson M, Rungby J.

Int J Mol Sci. 2020 Nov 20;21(22):8767. doi: 10.3390/ijms21228767.

Impact of arterial hypertension and its management strategies on cognitive function and dementia: a comprehensive umbrella review

Antonazzo B, Marano G, Romagnoli E, Ronzoni S, Frati G, Sani G, Janiri L, Mazza M.

Minerva Cardiol Angiol. 2022 Jun;70(3):285-297. doi: 10.23736/S2724-5683.20.05452-3. Epub 2020 Dec 1.

Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis

Chin KS, Yassi N, Churilov L, Masters CL, Watson R.

Parkinsonism Relat Disord. 2020 Nov;80:184-193. doi: 10.1016/j.parkreldis.2020.09.030. Epub 2020 Sep 23.

Exploring the molecular approach of COX and LOX in Alzheimer's and Parkinson's disorder

Kumar A, Behl T, Jamwal S, Kaur I, Sood A, Kumar P.

Mol Biol Rep. 2020 Dec;47(12):9895-9912. doi: 10.1007/s11033-020-06033-x. Epub 2020 Dec 2.

Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective

Yeong KY, Berdigaliyev N, Chang Y.

ACS Chem Neurosci. 2020 Dec 16;11(24):4073-4091. doi: 10.1021/acschemneuro.0c00696. Epub 2020 Dec 5.

Extracellular vesicles - propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases

Vassileff N, Cheng L, Hill AF.

J Cell Sci. 2020 Dec 11;133(23):jcs243139. doi: 10.1242/jcs.243139.

Neuromodulation for Cognitive Disorders: In Search of Lazarus?

Azmi H.

Neurol India. 2020 Nov-Dec;68(Supplement):S288-S296. doi: 10.4103/0028-3886.302469.

Common aspects between glaucoma and brain neurodegeneration

Saccà SC, Paluan F, Gandolfi S, Manni G, Cutolo CA, Izzotti A.

Mutat Res Rev Mutat Res. 2020 Oct-Dec;786:108323. doi: 10.1016/j.mrrev.2020.108323. Epub 2020 Aug 13.

Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases

Chen Z, Maqbool J, Sajid F, Hussain G, Sun T.

Microb Pathog. 2021 Jan;150:104675. doi: 10.1016/j.micpath.2020.104675. Epub 2020 Dec 24.

Research on developing drugs for Parkinson's disease

Zhang CL, Han QW, Chen NH, Yuan YH.

Brain Res Bull. 2021 Mar;168:100-109. doi: 10.1016/j.brainresbull.2020.12.017. Epub 2020 Dec 30.

Brain Disorders and Chemical Pollutants: A Gap Junction Link?

Mesnil M, Defamie N, Naus C, Sarrouilhe D.

Biomolecules. 2020 Dec 31;11(1):51. doi: 10.3390/biom11010051.

[Progress in lentiviral vector-mediated gene therapy for Alzheimer's disease and Parkinson's disease]

Xu D, Liu L, Lang M.

Sheng Wu Gong Cheng Xue Bao. 2020 Dec 25;36(12):2707-2718. doi: 10.13345/j.cjb.200177.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias